Ulthera to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
(firmenpresse) - MESA, AZ -- (Marketwired) -- 11/13/13 -- , Inc. -- a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications -- today announced it will be participating in the 2013 Canaccord Genuity Medical Technology & Diagnostics Forum on Thursday, November 14 at The Westin New York Grand Central in New York, NY.
Ulthera's presentation is scheduled for Thursday, November 14, 2013 at 2:00 pm EST.
Ulthera, Inc. is a global, high-growth medical device and specialty dermatology company with multiple aesthetic and medical applications using its therapeutic ultrasound platform technology. The Ulthera® System is the first and only energy-based device to receive U.S. FDA clearance for a non-invasive aesthetic lift indication. It is used in a face and neck procedure known as Ultherapy®, which is cleared to lift skin above the brow, on the neck and under the chin. Founded in 2004 and based in Mesa, Ariz., Ulthera is a privately held company backed by top-tier venture capital firms, and . For more information, visit .
Lindsey Karberg
Ulthera, Inc.
480.619.4069
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.11.2013 - 15:25 Uhr
Sprache: Deutsch
News-ID 1282948
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
MESA, AZ
Phone:
Kategorie:
Venture Capital
Anmerkungen:
Diese Pressemitteilung wurde bisher 84 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ulthera to Present at Canaccord Genuity Medical Technology & Diagnostics Forum
"
steht unter der journalistisch-redaktionellen Verantwortung von
Ulthera (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
